139 related articles for article (PubMed ID: 18501601)
21. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
[TBL] [Abstract][Full Text] [Related]
22. Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: involvement of PI3K/Akt, MAPKs, and mTOR.
Ryu JM; Lee MY; Yun SP; Han HJ
J Cell Physiol; 2009 Mar; 218(3):558-67. PubMed ID: 18988195
[TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
24. Baicalein suppresses hypoxia-induced HIF-1alpha protein accumulation and activation through inhibition of reactive oxygen species and PI 3-kinase/Akt pathway in BV2 murine microglial cells.
Hwang KY; Oh YT; Yoon H; Lee J; Kim H; Choe W; Kang I
Neurosci Lett; 2008 Oct; 444(3):264-9. PubMed ID: 18771709
[TBL] [Abstract][Full Text] [Related]
25. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
Zhang HY; Zhang PN; Sun H
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
[TBL] [Abstract][Full Text] [Related]
26. L-leucine increases [3H]-thymidine incorporation in chicken hepatocytes: involvement of the PKC, PI3K/Akt, ERK1/2, and mTOR signaling pathways.
Lee MY; Jo SD; Lee JH; Han HJ
J Cell Biochem; 2008 Dec; 105(6):1410-9. PubMed ID: 18980246
[TBL] [Abstract][Full Text] [Related]
27. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
Serra V; Markman B; Scaltriti M; Eichhorn PJ; Valero V; Guzman M; Botero ML; Llonch E; Atzori F; Di Cosimo S; Maira M; Garcia-Echeverria C; Parra JL; Arribas J; Baselga J
Cancer Res; 2008 Oct; 68(19):8022-30. PubMed ID: 18829560
[TBL] [Abstract][Full Text] [Related]
28. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
[TBL] [Abstract][Full Text] [Related]
29. Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
Garcia-Echeverria C; Sellers WR
Oncogene; 2008 Sep; 27(41):5511-26. PubMed ID: 18794885
[TBL] [Abstract][Full Text] [Related]
30. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
31. [Phosphoinositide 3-kinase/Akt pathway involved in regulation of hypoxia inducible factor 1alpha in hypoxia ischemia brain damage of neonatal rats].
Li L; Qu Y; Mao M; Mu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Sep; 22(9):1102-7. PubMed ID: 18822739
[TBL] [Abstract][Full Text] [Related]
32. Thrombin induces osteoprotegerin synthesis via phosphatidylinositol 3'-kinase/mammalian target of rapamycin pathway in human periodontal ligament cells.
Arayatrakoollikit U; Pavasant P; Yongchaitrakul T
J Periodontal Res; 2008 Oct; 43(5):537-43. PubMed ID: 18565131
[TBL] [Abstract][Full Text] [Related]
33. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons.
Chen TJ; Wang DC; Chen SS
J Neurosci Res; 2009 Aug; 87(10):2297-307. PubMed ID: 19301428
[TBL] [Abstract][Full Text] [Related]
34. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
35. Identification of a small-molecule inhibitor of class Ia PI3Ks with cell-based screening.
Yang J; Shamji A; Matchacheep S; Schreiber SL
Chem Biol; 2007 Apr; 14(4):371-7. PubMed ID: 17462572
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors.
Boovanahalli SK; Jin X; Jin Y; Kim JH; Dat NT; Hong YS; Lee JH; Jung SH; Lee K; Lee JJ
Bioorg Med Chem Lett; 2007 Nov; 17(22):6305-10. PubMed ID: 17884495
[TBL] [Abstract][Full Text] [Related]
37. Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway.
Powis G; Ihle N; Kirkpatrick DL
Clin Cancer Res; 2006 May; 12(10):2964-6. PubMed ID: 16707590
[No Abstract] [Full Text] [Related]
38. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation.
Bedogni B; Welford SM; Cassarino DS; Nickoloff BJ; Giaccia AJ; Powell MB
Cancer Cell; 2005 Dec; 8(6):443-54. PubMed ID: 16338658
[TBL] [Abstract][Full Text] [Related]
39. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
40. Discovery of trans-3,4'-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation.
Li Q; Li T; Zhu GD; Gong J; Claibone A; Dalton C; Luo Y; Johnson EF; Shi Y; Liu X; Klinghofer V; Bauch JL; Marsh KC; Bouska JJ; Arries S; De Jong R; Oltersdorf T; Stoll VS; Jakob CG; Rosenberg SH; Giranda VL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1679-85. PubMed ID: 16403626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
